A Win For Translate Bio, Inc.

Wed, Jun 12, 2024 at 07:30 PM
A Win For Translate Bio, Inc.

Translate Bio, Inc. (TBIO:NASDAQ) jumped higher at $4.34, representing a gain of 37.8%. On Wed, Jun 12, 2024, TBIO:NASDAQ hit a New 2-Week High of $4.34. From Wed, May 29, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days

The stock spiked on Fri, Feb 23, 2024 at $15.46 with a volume of 1M+.

About Translate Bio, Inc. (TBIO:NASDAQ)

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.